Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -28.85% is 49% below its 5-year average of -19.38%, near the low end of its 5-year range (-29.74%–-12.11%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.06% below its 12-month average of -27.99%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.85%.
RETURN ON EQUITY (ROE)
-28.85%
RETURN ON EQUITY (ROE) AVG TTM
-27.99%
RETURN ON EQUITY (ROE) AVG 3Y
-21.38%
RETURN ON EQUITY (ROE) AVG 5Y
-19.38%
RETURN ON EQUITY (ROE) AVG 10Y
-20.84%
RETURN ON EQUITY (ROE) AVG 15Y
-22.85%
RETURN ON EQUITY (ROE) AVG 20Y
-34.89%
CURRENT VS TTM AVG
-3.06%
CURRENT VS 3Y AVG
-34.97%
CURRENT VS 5Y AVG
-48.86%
CURRENT VS 10Y AVG
-38.47%
CURRENT VS 15Y AVG
-26.26%
CURRENT VS 20Y AVG
+17.30%
SECTOR MEDIAN · HEALTHCARE
-38.57%
median of 561 covered companies
CURRENT VS SECTOR MEDIAN
+25.20%
vs the sector median at left
MediciNova, Inc.
Market Cap
$83.18M
Return on Equity (ROE)
-28.85%
TTM Avg
-27.99%
3Y Avg
-21.38%
5Y Avg
-19.38%
Market Cap
$83.43M
Return on Equity (ROE)
N/A
TTM Avg
1.45%
3Y Avg
25.22%
5Y Avg
-14.52%
Market Cap
$82.69M
Return on Equity (ROE)
-85.65%
TTM Avg
-57.41%
3Y Avg
-45.73%
5Y Avg
-8.61%
Market Cap
$82.17M
Return on Equity (ROE)
-130.67%
TTM Avg
-143.13%
3Y Avg
-106.90%
5Y Avg
-90.63%
Market Cap
$82.16M
Return on Equity (ROE)
232.78%
TTM Avg
-18.33%
3Y Avg
-28.65%
5Y Avg
-29.96%
Market Cap
$84.58M
Return on Equity (ROE)
-50.80%
TTM Avg
-124.86%
3Y Avg
-88.30%
5Y Avg
-60.21%
Market Cap
$85.04M
Return on Equity (ROE)
-309.44%
TTM Avg
-515.53%
3Y Avg
-464.77%
5Y Avg
-329.14%
Market Cap
$80.89M
Return on Equity (ROE)
-114.06%
TTM Avg
-50.52%
3Y Avg
-45.18%
5Y Avg
-45.18%
Market Cap
$85.53M
Return on Equity (ROE)
-150.95%
TTM Avg
-77.89%
3Y Avg
-62.90%
5Y Avg
-47.80%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediciNova, Inc. (MNOV) | $83.18M | -28.85% | -27.99% | -21.38% | -19.38% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.43M | N/A | 1.45% | 25.22% | -14.52% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.69M | -85.65% | -57.41% | -45.73% | -8.61% |
| Nutriband Inc. (NTRB)vs › | $82.17M | -130.67% | -143.13% | -106.90% | -90.63% |
| LENSAR Inc (LNSR)vs › | $82.16M | 232.78% | -18.33% | -28.65% | -29.96% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.58M | -50.80% | -124.86% | -88.30% | -60.21% |
| Humacyte, Inc. (HUMA)vs › | $85.04M | -309.44% | -515.53% | -464.77% | -329.14% |
| Citius Oncology, Inc. (CTOR)vs › | $80.89M | -114.06% | -50.52% | -45.18% | -45.18% |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.53M | -150.95% | -77.89% | -62.90% | -47.80% |
| Pulmonx Corporation (LUNG)vs › | $80.04M | -122.76% | -82.75% | -63.80% | -49.10% |
ROE
-28.9%
ROA
-26.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -28.85% |
| 2026-03-31 | -29.74% |
| 2025-12-31 | -28.85% |
| 2025-09-30 | -27.32% |
| 2025-06-30 | -25.21% |
| 2025-03-31 | -22.35% |
| 2024-12-31 | -21.05% |
| 2024-09-30 | -18.69% |
| 2024-06-30 | -14.22% |
| 2024-03-31 | -14.05% |
| 2023-12-31 | -13.74% |
| 2023-09-30 | -14.71% |
| 2023-06-30 | -19.09% |
| 2023-03-31 | -20.08% |
| 2022-12-31 | -20.03% |
| 2022-09-30 | -17.99% |
| 2022-06-30 | -17.07% |
| 2022-03-31 | -16.59% |
| 2021-12-31 | -12.11% |
| 2021-09-30 | -12.76% |
| 2021-06-30 | -12.51% |
| 2021-03-31 | -12.26% |
| 2020-12-31 | -19.42% |
| 2020-09-30 | -17.47% |
| 2020-06-30 | -16.21% |
| 2020-03-31 | -14.97% |
| 2019-12-31 | -17.28% |
| 2019-09-30 | -15.02% |
| 2019-06-30 | -21.27% |
| 2019-03-31 | -19.76% |
| 2018-12-31 | -20.07% |
| 2018-09-30 | -21.85% |
| 2018-06-30 | -17.26% |
| 2018-03-31 | -16.79% |
| 2017-12-31 | -28.89% |
| 2017-09-30 | -31.71% |
| 2017-06-30 | -30.22% |
| 2017-03-31 | -32.06% |
| 2016-12-31 | -31.47% |
| 2016-09-30 | -34.00% |
| 2016-06-30 | -29.23% |
| 2016-03-31 | -25.58% |
| 2015-12-31 | -27.01% |
| 2015-09-30 | -24.52% |
| 2015-06-30 | -46.24% |
| 2015-03-31 | -43.24% |
| 2014-12-31 | -41.78% |
| 2014-09-30 | -14.80% |
| 2014-06-30 | -13.30% |
| 2014-03-31 | -14.87% |
| 2013-12-31 | -15.84% |
| 2013-09-30 | -46.05% |
| 2013-06-30 | -43.65% |
| 2013-03-31 | -66.77% |
| 2012-12-31 | -73.66% |
| 2012-09-30 | -72.04% |
| 2012-06-30 | -75.80% |
| 2012-03-31 | -77.49% |
| 2011-12-31 | -75.47% |
| 2011-09-30 | -99.84% |
| 2011-06-30 | -92.44% |
| 2011-03-31 | -76.13% |
| 2010-12-31 | -81.72% |
| 2010-09-30 | -72.26% |
| 2010-06-30 | -58.92% |
| 2010-03-31 | -55.34% |
| 2009-12-31 | -50.91% |
| 2009-09-30 | -44.26% |
| 2009-06-30 | -40.00% |
| 2009-03-31 | -36.84% |
| 2008-12-31 | -45.63% |
| 2008-09-30 | -48.85% |
| 2008-06-30 | -54.93% |
| 2008-03-31 | -77.20% |
| 2007-12-31 | -73.42% |
| 2007-09-30 | -83.70% |
| 2007-06-30 | -71.34% |
| 2007-03-31 | -44.63% |
| 2006-12-31 | -35.34% |
| 2006-09-30 | -27.90% |
| 2006-06-30 | -24.40% |
| 2006-03-31 | -23.04% |
| 2005-12-31 | -18.93% |
| 2005-09-30 | -15.69% |
| 2005-06-30 | -22.51% |
| 2005-03-31 | -29.68% |
| 2004-12-31 | -629.44% |
